Drance S M, Saheb N E, Schulzer M
Arch Ophthalmol. 1978 Jun;96(6):1001-2. doi: 10.1001/archopht.1978.03910050525004.
The epinephrine pressure reduction was determined in 32 patients with elevated intraocular pressure (IOP) and 18 patients with untreated chronic open-angle glaucoma. The prevalence of responders was 53% of those patients with elevated IOP and 56% in those patients with open-angle glaucoma. This lack of difference between the two groups is suggestive of the need for caution before applying epinephrine in clinical practice as a predictive factor of future field loss.
对32例眼压升高患者和18例未经治疗的慢性开角型青光眼患者测定了肾上腺素降压效果。眼压升高患者中反应者的患病率为53%，开角型青光眼患者中为56%。两组之间缺乏差异表明，在临床实践中将肾上腺素作为未来视野缺损的预测因素应用之前需要谨慎。
